GlassScriptPhysician profile
Clark Higganbotham
NPI 1164042560
$3,193.69
in general payments reported to CMS, 2019-2025
11 companies · $610 in 2025
The $610 reported for 2025 was more than what 82% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $60.24 · 2022: $50.67 · 2023: $469 · 2024: $2,003 · 2025: $610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,780 · Travel and Lodging: $1,303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,780.17 |
| Travel and Lodging | $1,302.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,544.54 | 2021-2025 | Accolade Sr, Ams 700, Advance Xp |
| Janssen Scientific Affairs, LLC | $148.69 | 2024-2025 | Erleada, Akeega, Balversa |
| Calyxo, INC. | $144.99 | 2025 | Cvac Aspiration System |
| Sumitomo Pharma America, INC. | $109.44 | 2023 | Gemtesa |
| Urogen Pharma, INC. | $66.31 | 2023 | Jelmyto |
| Progenics Pharmaceuticals, INC. | $52.85 | 2024 | |
| Photocure INC | $39.61 | 2025 | Cysview |
| Myriad Genetic Laboratories, INC. | $37.44 | 2023 | Prolaris |
| Axonics, INC. | $20.56 | 2024 | Axonics |
| Palette Life Sciences, INC. | $17.47 | 2022 | |
| Allergan, INC. | $11.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clark Higganbotham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.